Futures Rebound as Oil Falls
Stock futures rebounded early Monday as investors were optimistic that the conflict between Israel and Iran may remain contained. The spike in oil prices due to the escalating conflict also eased.Futures for the Dow Jones Industrials popped 255 points, or 0.6%, to 42,778.Futures for the S&P 500 index hiked 39.75 points, or 0.7%, to 6,071.25Futures for the NASDAQ cruised 178.50 points, or 0.8%, to 22,039.25Traders have been closely watching the Middle East after Israel’s strike on Iran Friday. Iran launched missiles in retaliation, increasing the severity of conflict in the region.The attacks continued for a fourth day Monday, with the two countries targeting each others’ energy facilities, an escalation which could rattle the global economy and markets further in the new week. Iran said it is considering shutting down the Strait of Hormuz, a key route for the global oil market. Israel claimed on Monday to have achieved “aerial superiority” over Iran, according to a military spokesperson.Investors will monitor manufacturing survey data due Monday morning, which comes ahead of the Federal Reserve’s interest rate decision on Wednesday. Fed funds futures are pricing in a nearly 100% likelihood of the central bank keeping rates unchanged, even as President Donald Trump has been pressuring Fed Chief Jerome Powell for a rate cut. In Japan, the Nikkei 225 index regained 1.3% Monday, while in Hong Kong, the Hang Seng added 0.7%Oil prices dipped 87 cents to $72.11 U.S. a barrel. Gold prices fell $17.20 to $3,435.60 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


